My Quote Request
No products added yet
6505-01-150-2100
20 Products
NDC58768-0130-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011502100
NSN
6505-01-150-2100
NDC58768-0130-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011502100
NSN
6505-01-150-2100
MFG
COOPER LABORATORIES INC COOPER VISION PHARMACEUTICALS INC DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,IOLAB CORP
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
NDC00058-0130-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011502100
NSN
6505-01-150-2100
NDC00058-0130-30
ARTIFICIAL TEARS SOLUTION
NSN, MFG P/N
6505011502100
NSN
6505-01-150-2100
MFG
IOLAB CORP IOLAB PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,IOLAB CORP
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
Related Searches:
NDC00002-3061-02
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
NDC00002-3061-02
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.17 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFACLOR ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00172-4770-60
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
NDC00172-4770-60
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
MFG
ZENITH LABORATORIES INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.17 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFACLOR ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0317-05
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
NDC00378-0317-05
CEFACLOR CAPSULES,USP
NSN, MFG P/N
6505011502101
NSN
6505-01-150-2101
MFG
MYLAN PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 6
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.17 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFACLOR ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFACLOR CAPSULES USP 250MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CYCLOCORT
AMCINONIDE OINTMENT,USP
NSN, MFG P/N
6505011503824
NSN
6505-01-150-3824
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE OINTMENT USP 0.1% 60GM COLLAPSIBLE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
NDC00469-7115-60
AMCINONIDE OINTMENT,USP
NSN, MFG P/N
6505011503824
NSN
6505-01-150-3824
NDC00469-7115-60
AMCINONIDE OINTMENT,USP
NSN, MFG P/N
6505011503824
NSN
6505-01-150-3824
MFG
ASTELLAS PHARMA US INC.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.100 AMCINONIDE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMCINONIDE OINTMENT USP 0.1% 60GM COLLAPSIBLE TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, COLLAPSIBLE
Related Searches:
3030
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011503875
NSN
6505-01-150-3875
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 USP UNITS HEPARIN PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL,MULTIPLE DOSE
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00467-3030-25
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011503875
NSN
6505-01-150-3875
NDC00467-3030-25
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011503875
NSN
6505-01-150-3875
MFG
INVENEX LABORATORIES LIFE TECHNOLOGIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 USP UNITS HEPARIN PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL,MULTIPLE DOSE
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
7194
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
7194
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 1ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
NDC00002-7194-01
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
NDC00002-7194-01
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 1ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
ONCOVIN SOLUTION
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
ONCOVIN SOLUTION
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011504949
NSN
6505-01-150-4949
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 1ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
Related Searches:
IMURAN
AZATHIOPRINE SODIUM
NSN, MFG P/N
6505011504950
NSN
6505-01-150-4950
MFG
BURROUGHS WELLCOME CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH ML CONTAINS EQUIVALENT OF 5 MG AZATHIOPRINE; 20 ML VIAL
Related Searches:
NDC00081-0598-71
AZATHIOPRINE SODIUM
NSN, MFG P/N
6505011504950
NSN
6505-01-150-4950
MFG
BURROUGHS WELLCOME CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH ML CONTAINS EQUIVALENT OF 5 MG AZATHIOPRINE; 20 ML VIAL
Related Searches:
LIORESAL DS
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS BACLOFEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZENITH LABS
Related Searches:
LIORESAL DS TABLETS
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
LIORESAL DS TABLETS
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS BACLOFEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZENITH LABS
Related Searches:
NDC00028-0033-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
NDC00028-0033-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
MFG
CIBA-GEIGY CORP GEIGY PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS BACLOFEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZENITH LABS
Related Searches:
NDC00172-4097-60
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
NDC00172-4097-60
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS BACLOFEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZENITH LABS
Related Searches:
NDC00364-2313-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
NDC00364-2313-01
BACLOFEN TABLETS,USP
NSN, MFG P/N
6505011504970
NSN
6505-01-150-4970
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS BACLOFEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACLOFEN TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ZENITH LABS
Related Searches:
5K2094
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
5K2094
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 624.000 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 223.000 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 847.000 GRAMS
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: TO BE RECONSTITUTED TO 2.5 GALLONS (9.46 LITERS) PER PACKET; FOR USE WITH SB-1000 AND SB-1003 BICARBONATE CONCENTRATES IN A THREE STREAM PROPORTIONING MACHINE
TOTAL PRIMARY CONTAINER QUANTITY: 20
